ISSN:

Journal Home

Journal Guideline

Clinical Neuropsychopharmacology and Therapeutics Q4 Unclaimed

Japanese Society of Clinical Neuropsychopharmacology Japan

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Clinical Neuropsychopharmacology and Therapeutics is a journal indexed in SJR in Neurology (clinical) and Psychiatry and Mental Health with an H index of 1. It has an SJR impact factor of 0,125 and it has a best quartile of Q4. It has an SJR impact factor of 0,125.

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Neurology (clinical) (Q4) Pharmacology (medical) (Q4) Psychiatry and Mental Health (Q4)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Clinical Neuropsychopharmacology and Therapeutics

0,125

SJR Impact factor

1

H Index

0

Total Docs (Last Year)

1

Total Docs (3 years)

0

Total Refs

0

Total Cites (3 years)

1

Citable Docs (3 years)

0

Cites/Doc (2 years)

0.0

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Ideggyogyaszati Szemle Q4
Progress in Neurology and Psychiatry Q4
Case Reports in Neurology Q4
Future Neurology Q4
NeuroRegulation Q4

Compare this journals

Clinical Neuropsychopharmacology and Therapeutics Q4 Unclaimed

- €

NPD

- €

Metrics

0,125

1

0

1

0

0

1

0

0.0

Comments

Other journals with similar parameters

Aims and Scope

FAQS

What is the impact factor of Clinical Neuropsychopharmacology and Therapeutics?